Key Takeaways
- Dow Inc. surpassed Q2 revenue projections with $12.09B compared to the $12.03B analyst consensus, while adjusted EPS reached $1.44 versus the $1.28 forecast.
- The chemical giant swung to a net profit of $802M from an $801M loss in the prior-year quarter.
- Shares retreated 2.8% during premarket hours Thursday following the earnings announcement.
- Rising polyethylene prices fueled a 20% surge in net sales, though total volumes contracted 1%.
- The company increased its restructuring program savings forecast to over $1.3B by 2026, approximately $200M higher than the previous estimate.
Dow Inc. (DOW) delivered second-quarter results that exceeded analyst projections on both the top and bottom lines. Yet investors responded with skepticism — shares declined 2.8% in Thursday’s premarket session to approximately $31.25 as the chemical manufacturer highlighted weakening demand trends, volume contractions and elevated cost pressures.
As of Wednesday’s market close, DOW shares had appreciated 34% since the beginning of the year.
The company reported quarterly revenue of $12.09 billion, marginally exceeding the Street’s $12.03 billion projection. Adjusted earnings per share totaled $1.44, comfortably surpassing the anticipated $1.28.
Bottom-line performance showed dramatic improvement, with net income reversing from a year-ago loss of $801 million, or $1.18 per diluted share, to earnings of $802 million, or $0.99 per share.
The underlying narrative centers on pricing strength rather than volume growth. Net sales advanced 20% compared to the year-earlier period, propelled by a corresponding 20% increase in local pricing — with polyethylene price gains leading the way globally. In contrast, aggregate sales volumes contracted 1%.
Packaging Division Shines Despite Volume Headwinds
The Packaging & Specialty Plastics division emerged as the primary growth driver, with revenues advancing 27% to reach $6.4 billion. Operating earnings jumped dramatically to $1.28 billion versus just $71 million in the comparable quarter last year. Elevated polyethylene pricing powered these results, compensating for a 4% volume decline attributed to scheduled maintenance activities.
The company noted that customer demand across Europe, the Middle East, Africa, India and Asia Pacific regions faced headwinds from the continuing Middle East conflict.
The Industrial Intermediates & Infrastructure division recorded 14% revenue growth, supported by improved pricing, although volumes softened due to reduced construction chemicals appetite and Middle Eastern geopolitical disruptions.
Performance Materials & Coatings achieved an 11% sales increase, benefiting from robust downstream demand in silicones and coatings applications. However, operating income fell 13%, pressured by elevated fixed expenses, turnaround-related costs and an unexpected outage at the company’s siloxanes facility in Barry, United Kingdom.
Restructuring Initiative Gains Momentum
Chief Executive Karen Carter stated the organization “delivered strong second quarter results through disciplined and timely execution,” highlighting the company’s accelerated self-improvement initiatives.
Management elevated the projected benefits from its Transform to Outperform restructuring initiative to exceed $1.3 billion by 2026 — representing roughly $200 million above the previously communicated target. Leadership anticipates these benefits will continue building momentum throughout the remainder of this year and extending into 2027.
Notably absent from the quarterly report was any updated financial outlook for the latter half of the year. This omission, coupled with volume declines spanning all three operating divisions, appears to have triggered the cautious investor response.
Volume metrics showed weakness across the enterprise, with Industrial Intermediates experiencing a 2% contraction, while management acknowledged persistent challenges from Middle Eastern disruptions and increased turnaround expenditures within Performance Materials & Coatings.
Shares currently trade at $31.25, considerably below the 52-week peak of $42.74.





